Das Universitätsklinikum Hamburg-Eppendorf, bis 2001 Universitätskrankenhaus Eppendorf, ist ein Krankenhaus der Universität Hamburg im Hamburger Stadtteil Eppendorf.

During the past decade, University Medical Center Hamburg-Eppendorf conducted 95 clinical trials. In the 10-year time frame, 95 clinical trials started and 9 clinical trials were completed, i.e. on average, 9.5% percent of trials that started reached the finish line to date. In the past 5 years, 46 clinical trials started and 5 clinical trials were completed. i.e. 10.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Medical Center Hamburg-Eppendorf" #1 sponsor was "Universitätsklinikum Hamburg-Eppendorf" with 87 trials, followed by "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 4 trials sponsored, "Allievex Corporation" with 3 trials sponsored, "Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany" with 3 trials sponsored and "Dutch Childhood Oncology Group" with 3 trials sponsored. Other sponsors include 55 different institutions and companies that sponsored additional 59 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Medical Center Hamburg-Eppendorf" #1 collaborator was "Universitätsklinikum Hamburg-Eppendorf" with 5 trials as a collaborator, "Clinical Trial Center North (CTC North GmbH & Co. KG)" with 3 trials as a collaborator, "German Federal Ministry of Education and Research" with 3 trials as a collaborator, "Philipps University Marburg Medical Center" with 3 trials as a collaborator and "University of Rostock" with 3 trials as a collaborator. Other collaborators include 141 different institutions and companies that were collaborators in the rest 143 trials.

According to Clinical.Site data, the most researched conditions in "University Medical Center Hamburg-Eppendorf" are "Leukemia" (7 trials), "Lymphoma" (6 trials), "Depression" (4 trials), "Neuroblastoma" (4 trials) and "Stroke" (4 trials). Many other conditions were trialed in "University Medical Center Hamburg-Eppendorf" in a lesser frequency.

Most popular intervention types in "University Medical Center Hamburg-Eppendorf" are "Drug" (57 trials), "Procedure" (28 trials), "Other" (24 trials), "Biological" (20 trials) and "Behavioral" (15 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "vincristine sulfate" (10 trials), "cyclophosphamide" (9 trials), "radiation therapy" (8 trials) and "doxorubicin hydrochloride" (7 trials). Other intervention names were less common.

The vast majority of trials in "University Medical Center Hamburg-Eppendorf" are 150 trials for "All" genders, 5 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are 51 active trials in "University Medical Center Hamburg-Eppendorf". 2 are not yet recruiting, 30 are recruiting, 17 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 81 completed trials in University Medical Center Hamburg-Eppendorf, 1 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in University Medical Center Hamburg-Eppendorf, 7 "Phase 1" clinical trials were conducted, 35 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 48 trials that are defined as “Not Applicable".